← Evidence map

ArticleThe World Allergy Organization journal2026

Prevalence and cost implications of broadening asthma biologic eligibility criteria.

Freda Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42662812